News & Updates
Filter by Specialty:
Primary PCI strategy reduces death rates in STEMI patients
Between 2003 and 2018, 1-year mortality has decreased considerably in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) in a high-income European country with a fully implemented primary PCI strategy, reports a study.
Primary PCI strategy reduces death rates in STEMI patients
09 Sep 2023
Dapagliflozin safe, effective in HF patients across global regions
Dapagliflozin for individuals with heart failure (HF) demonstrates consistent safety and efficacy across regions worldwide despite geographic differences in patient characteristics, background treatment, and event rates, reports a recent study.
Dapagliflozin safe, effective in HF patients across global regions
08 Sep 2023
Worsening kidney function ups ASCVD risk
Individuals with worsening kidney function are at greater risk of future atherosclerotic cardiovascular diseases (ASCVD), and such risk is more evident among women, according to a study.
Worsening kidney function ups ASCVD risk
05 Sep 2023
Heart failure, death risks elevated within 10 years after myocardial infarction
Nearly one in three patients with myocardial infarction (MI) develop heart failure or renal failure, while a few of them experience another MI or, worse, die within 10 years, according to a study in England.